Keywords: valeant, sees, 4th-qtr, revenues, slide, usa-based, pharmaceuticals
Valeant sees 4th-qtr 2003 revenues slide
Article | 15 March 2004
USA-based Valeant Pharmaceuticals (formerly ICN Pharmaceuticals) saw its turnover in the fourth quarter of 2003 fall to $176.2 million from $199.6 million in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
